Specific Proteins - Medical Devices Pipeline Assessment, 2019
Summary
The Publisher's Medical Devices sector report, “Specific Proteins - Medical Devices Pipeline Assessment, 2019" provides an overview of Specific Proteins currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Specific Proteins pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the Publisher's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Reasons to Buy
The report enables you to:
Summary
The Publisher's Medical Devices sector report, “Specific Proteins - Medical Devices Pipeline Assessment, 2019" provides an overview of Specific Proteins currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Specific Proteins pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the Publisher's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Specific Proteins under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Specific Proteins and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Specific Proteins under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1.1 List of Tables1.2 List of Figures
2 Introduction
2.1 Specific Proteins Overview
3 Products under Development
3.1 Specific Proteins - Pipeline Products by Stage of Development
3.2 Specific Proteins - Pipeline Products by Territory
3.3 Specific Proteins - Pipeline Products by Regulatory Path
3.4 Specific Proteins - Pipeline Products by Estimated Approval Date
4 Specific Proteins - Pipeline Products under Development by Companies
4.1 Specific Proteins Companies - Pipeline Products by Stage of Development
4.2 Specific Proteins - Pipeline Products by Stage of Development
5 Specific Proteins Companies and Product Overview
5.1 Abbott Diagnostics Company Overview
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.2 Alfa Wassermann Diagnostic Technologies, LLC Company Overview
5.2.1 Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.3 Amerimmune LLC Company Overview
5.3.1 Amerimmune LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Analyticon Biotechnologies AG Company Overview
5.4.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
5.5 Beckman Coulter Inc Company Overview
5.5.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 China Medical Technologies Inc (Inactive) Company Overview
5.6.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.7 Colorado State University Company Overview
5.7.1 Colorado State University Pipeline Products & Ongoing Clinical Trials Overview
5.8 Fujirebio Diagnostics Inc Company Overview
5.8.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Genesis Detection Systems, Inc. Company Overview
5.9.1 Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.10 Genome Diagnostics Pvt. Ltd. Company Overview
5.10.1 Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.11 Guanine Inc Company Overview
5.11.1 Guanine Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Hologic Inc Company Overview
5.12.1 Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Isoformix Inc Company Overview
5.13.1 Isoformix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Kobe University Company Overview
5.14.1 Kobe University Pipeline Products & Ongoing Clinical Trials Overview
5.15 Ortho-Clinical Diagnostics Inc Company Overview
5.15.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Ottawa Hospital Research Institute Company Overview
5.16.1 Ottawa Hospital Research Institute Pipeline Products & Ongoing Clinical Trials Overview
5.17 Roche Diagnostics International Ltd Company Overview
5.17.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.18 Sebia SA Company Overview
5.18.1 Sebia SA Pipeline Products & Ongoing Clinical Trials Overview
5.19 Siemens Healthcare Diagnostics Inc Company Overview
5.19.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Siemens Healthineers AG Company Overview
5.20.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
5.21 The Binding Site Group Ltd Company Overview
5.21.1 The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.22 Umea University Company Overview
5.22.1 Umea University Pipeline Products & Ongoing Clinical Trials Overview
5.23 University of California Company Overview
5.23.1 University of California Pipeline Products & Ongoing Clinical Trials Overview
6 Specific Proteins- Recent Developments
6.1 Oct 30, 2019: PerkinElmer announces financial results for the third quarter of 2019
6.2 Oct 29, 2019: ELITechGroup announces direct sales and customer support in Canada
6.3 Oct 23, 2019: bioMerieux - Third-Quarter 2019 Business Review
6.4 Oct 22, 2019: bioMerieux - Third quarter 2019 business review
6.5 Oct 21, 2019: SomaLogic significantly expands key strategic collaboration with Novartis
6.6 Oct 16, 2019: Abbott reports third-quarter 2019 results
6.7 Oct 01, 2019: Opthea receives A$14.6mR&D tax incentive
6.8 Sep 04, 2019: bioMerieux announces First-Half 2019 Results
6.9 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership
6.10 Aug 21, 2019: PerkinElmer announces leadership succession plan
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer
List of Tables
Table 1: Specific Proteins - Pipeline Products by Stage of Development
Table 2: Specific Proteins - Pipeline Products by Territory
Table 3: Specific Proteins - Pipeline Products by Regulatory Path
Table 4: Specific Proteins - Pipeline Products by Estimated Approval Date
Table 5: Specific Proteins Companies - Pipeline Products by Stage of Development
Table 6: Specific Proteins - Pipeline Products by Stage of Development
Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Alinity c Assay - Cystatin C - Product Status
Table 9: Alinity c Assay - Cystatin C - Product Description
Table 10: Alinity c Assay - Immunoglobulin E - Product Status
Table 11: Alinity c Assay - Immunoglobulin E - Product Description
Table 12: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 13: ACE Axcel System - Lp(a) Assay - Product Status
Table 14: ACE Axcel System - Lp(a) Assay - Product Description
Table 15: ACE Axcel System - Microalbumin Assay - Product Status
Table 16: ACE Axcel System - Microalbumin Assay - Product Description
Table 17: ACE Axcel System - Transferrin Assay - Product Status
Table 18: ACE Axcel System - Transferrin Assay - Product Description
Table 19: Amerimmune LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 20: FoxP3 Protein Expression Assay - Product Status
Table 21: FoxP3 Protein Expression Assay - Product Description
Table 22: Wiscott-Aldrich Protein Expression Assay - Product Status
Table 23: Wiscott-Aldrich Protein Expression Assay - Product Description
Table 24: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Turbitex C 3c Reagent - Product Status
Table 26: Turbitex C 3c Reagent - Product Description
Table 27: Turbitex C 4 Reagent - Product Status
Table 28: Turbitex C 4 Reagent - Product Description
Table 29: Turbitex CRP Reagent - Product Status
Table 30: Turbitex CRP Reagent - Product Description
Table 31: Turbitex CRP Ultra Reagent - Product Status
Table 32: Turbitex CRP Ultra Reagent - Product Description
Table 33: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Access - sFlt-1 Assay - Product Status
Table 35: Access - sFlt-1 Assay - Product Description
Table 36: UniCel DxC 600i Synchron Access Clinical System - sFlt-1 Assay - Product Status
Table 37: UniCel DxC 600i Synchron Access Clinical System - sFlt-1 Assay - Product Description
Table 38: UniCel DxC 680i Synchron Access Clinical System - PlGF Assay - Product Status
Table 39: UniCel DxC 680i Synchron Access Clinical System - PlGF Assay - Product Description
Table 40: UniCel DxC 680i Synchron Access Clinical System - sFlt-1 Assay - Product Status
Table 41: UniCel DxC 680i Synchron Access Clinical System - sFlt-1 Assay - Product Description
Table 42: UniCel DxC 860i Synchron Access Clinical System - PlGF Assay - Product Status
Table 43: UniCel DxC 860i Synchron Access Clinical System - PlGF Assay - Product Description
Table 44: UniCel DxC 860i Synchron Access Clinical System - sFlt-1 Assay - Product Status
Table 45: UniCel DxC 860i Synchron Access Clinical System - sFlt-1 Assay - Product Description
Table 46: UniCel DxC 880i Synchron Access Clinical System - PlGF Assay - Product Status
Table 47: UniCel DxC 880i Synchron Access Clinical System - PlGF Assay - Product Description
Table 48: UniCel DxC 880i Synchron Access Clinical System - sFlt-1 Assay - Product Status
Table 49: UniCel DxC 880i Synchron Access Clinical System - sFlt-1 Assay - Product Description
Table 50: UniCel DxI 600 Access Immunoassay System - PlGF Assay - Product Status
Table 51: UniCel DxI 600 Access Immunoassay System - PlGF Assay - Product Description
Table 52: UniCel DxI 600 Access Immunoassay System - sFlt-1 Assay - Product Status
Table 53: UniCel DxI 600 Access Immunoassay System - sFlt-1 Assay - Product Description
Table 54: UniCel DxI 660i Synchron Access Clinical System - sFlt-1 Assay - Product Status
Table 55: UniCel DxI 660i Synchron Access Clinical System - sFlt-1 Assay - Product Description
Table 56: UniCel DxI 800 Access Immunoassay System - PlGF Assay - Product Status
Table 57: UniCel DxI 800 Access Immunoassay System - PlGF Assay - Product Description
Table 58: UniCel DxI 800 Access Immunoassay System - sFlt-1 Assay - Product Status
Table 59: UniCel DxI 800 Access Immunoassay System - sFlt-1 Assay - Product Description
Table 60: UniCel DxI 860i Synchron Access Clinical System - PlGF Assay - Product Status
List of Figures
Figure 1: Specific Proteins - Pipeline Products by Stage of Development
Figure 2: Specific Proteins - Pipeline Products by Territory
Figure 3: Specific Proteins - Pipeline Products by Regulatory Path
Figure 4: Specific Proteins - Pipeline Products by Estimated Approval Date
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Diagnostics
- Alfa Wassermann Diagnostic Technologies, LLC
- Amerimmune LLC
- Analyticon Biotechnologies AG
- Beckman Coulter Inc
- Colorado State University
- Fujirebio Diagnostics Inc
- Genesis Detection Systems, Inc.
- Genome Diagnostics Pvt. Ltd.
- Guanine Inc
- Hologic Inc
- Isoformix Inc
- Kobe University
- Ortho-Clinical Diagnostics Inc
- Ottawa Hospital Research Institute
- Roche Diagnostics International Ltd
- Sebia SA
- Siemens Healthcare Diagnostics Inc
- Siemens Healthineers AG
- The Binding Site Group Ltd
- Umea University
- University of California
